← Open Payments lookup

FRANCIS BAYACA: Open Payments

NPI 1427067768 · WATSONVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,212 in 56 payments from 19 companies in 2025. Trend: 2023 $1,326 · 2024 $1,718 · 2025 $1,212

Food & beverage: $1,212
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.12$226
Bayer Healthcare Pharmaceuticals Inc.8$174
Novo Nordisk Inc6$147
Viatris Specialty LLC5$126
GlaxoSmithKline, LLC.4$84
AstraZeneca Pharmaceuticals LP4$79
Teva Pharmaceuticals USA, Inc.2$63
PFIZER INC.3$62
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39
Amgen Inc.1$32

Products named: REXULTI, Kerendia, YUPELRI, Ozempic, TRELEGY ELLIPTA, AUSTEDO XR, PAXLOVID, LOKELMA.

Industry payments across CA — which companies pay providers there.